We observed a significant enhancement in AST, ALP, LDH, TG, and MDA levels and diminution in GSH amount, and SOD, CAT and GPX activity as well as microvesicular steatosis and periportal inflammation in BPA-treated rats. The gene discussed is SOD1; the disease is steatosis.